These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7165005)

  • 1. Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung.
    Samson MK; Baker LH; Cummings G; Talley RW
    Am J Clin Oncol; 1982 Dec; 5(6):631-3. PubMed ID: 7165005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer.
    Child JA; Bono AV; Fossa SD; Ten Bokkel Huinink WW; De Pauw M; Stoter G
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):85-7. PubMed ID: 7200896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
    Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF
    Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe neurotoxicity with methyl G: CALGB experience.
    Spaulding MB; Barron SS; Comis RL; Richards F; Kennedy BJ; Pajak TF
    Med Pediatr Oncol; 1982; 10(5):521-4. PubMed ID: 6292681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
    Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
    Cancer Clin Trials; 1981; 4(4):389-91. PubMed ID: 6274532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
    Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
    Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
    Thongprasert S; Bosl GJ; Geller NL; Wittes RE
    Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trials of methylglyoxal-bis (guanylhydrazone).
    Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW
    Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
    Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
    Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus.
    Forastiere AA; Gennis M; Orringer MB; Agha FP
    J Clin Oncol; 1987 Aug; 5(8):1143-9. PubMed ID: 3625244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
    Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
    Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of AMSA in lung cancer.
    Samson MK; Fraile RJ; Baker LH; Cummings G; Talley RW
    Cancer Treat Rep; 1981; 65(7-8):655-8. PubMed ID: 6265083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.
    Killen JY; Mitchell EP; Hoth DF; Willis LL; Gullo JJ; Smith FP; Schein PS; Woolley PV
    Cancer; 1982 Oct; 50(7):1258-61. PubMed ID: 7104970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinoma.
    Arteaga CL; Clark GM
    Invest New Drugs; 1989 Jul; 7(2-3):281-3. PubMed ID: 2793385
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 19. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group.
    Knight WA; O'Bryan RM; Samal B; Costanzi JJ
    Invest New Drugs; 1984; 2(1):71-3. PubMed ID: 6469501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of cisplatin and methylglyoxal bis-guanylhydrazone (MGBG) in recurrent squamous cell carcinoma of the head and neck.
    Takasugi BJ; Perry DJ; Wheeler RH; Forastiere AA
    Am J Clin Oncol; 1986 Aug; 9(4):299-301. PubMed ID: 3751967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.